Author(s)

Joanna Byrne

Affiliation(s)

Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia.

Corresponding Author

Joanna Byrne

ABSTRACT

Metastasis and recurrence are regarded as core factors affecting the prognosis of malignant tumors. In the basic theoretical components of metastasis and recurrence, tumor cell groups use the circulatory system to transport to distant organs, just like seeds spread in the soil, forming metastases with characteristics similar to those of the original tumors. The metastasis theory vividly It clarified the metastasis channels of malignant tumors and pointed out that "seed" tumor cells, also known as circulating tumor cells, are the focus of tumor metastasis and recurrence, and have a reliable basis for clinical analysis. In recent years, circulating tumor cells (CTCs), as potential biomarkers of tumor biology and tumor metastasis, have aroused great enthusiasm among oncologists and have become a hot topic in tumor biology analysis. This article reviews the clinical value of circulating tumor cells in non-small cell lung cancer and its clinical analysis, especially the diagnosis and treatment of lung cancer.

KEYWORDS

Non-small cell lung cancer; Circulating tumor cells; Liquid biopsy

CITE THIS PAPER

Joanna Byrne. Utility of circulating tumor cells in enhancing the therapeutic strategies for non-small cell lung cancer. World Journal of Clinical Sciences. 2024, 2(2): 1-5. DOI: 10.61784/wjcsv2n232.

REFERENCES

[1] Zhai Xin. Analysis of distribution patterns of TCM syndrome types and related factors in patients with non-small cell lung cancer after surgery. Zhejiang University of Traditional Chinese Medicine, 2018.

[2] Zheng Qiaorui. Study on the correlation between circulating tumor cells and Ki-67 in non-small cell lung cancer. Guangxi Medical University, 2018.

[3] Zeng Li. Study on the correlation between ctDNA monitoring and the efficacy of radiotherapy for non-small cell lung cancer. Guangxi Medical University, 2018.

[4] Chen Zhongqing. Study on the value of six tumor markers in the diagnosis of non-small cell lung cancer. Guangxi Medical University, 2018.

[5] Rong Rong. A new grid-shaped micro-nano chip method for capturing circulating tumor cells in patients with non-small cell lung cancer. Anhui Medical University, 2018.

[6] Shao Yue. The significance of tumor testis antigen AKAP4 in the early diagnosis of non-small cell lung cancer. Dalian Medical University, 2018.

[7] Wen Yuxiang. Study on plasma metabolomics related to the efficacy of bevacizumab in the treatment of non-small cell lung cancer. Beijing Jiaotong University, 2018.

[8] Gao Kun. Treatment of brain metastases from non-small cell lung cancer. Hebei Medical University, 2018.

[9] Zhao Xueyu. Retrospective clinical study on the effect of integrated traditional Chinese and Western medicine treatment on postoperative patients with stage II-IIIA non-small cell lung cancer. Yangzhou University, 2018.

[10] Xu Xiaoyan. Meta-analysis of the prognostic value of baseline circulating tumor cell levels detected by the CellSearch system for small cell lung cancer. Qingdao University, 2018.

[11] Yin Gaozheng. Clinical study on detecting T790M mutation status in blood of EGFR-TKI-resistant patients with non-small cell lung cancer based on NGS technology. Qingdao University, 2018.

[12] Xu Wei. Study on the effect of indomethacin on down-regulating E2F1 gene expression in small cell lung cancer on cell metastasis and invasiveness. Qingdao University, 2018.

[13] Jia Pengfei. A preliminary study on the prescription drugs and compatibility rules of Professor Wang Pei’s traditional Chinese medicine for the treatment of non-small cell lung cancer based on data mining technology. Beijing University of Chinese Medicine, 2018.

[14] Zhang Hong. Effect of Erchen Decoction on CD4+T lymphocyte subsets in patients with metastatic non-small cell lung cancer undergoing chemotherapy with phlegm syndrome. Beijing University of Chinese Medicine, 2018.

[15] Zhu Saijun. Application research and mechanism exploration of Fuzheng Sanjie Recipe combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Nanjing University of Traditional Chinese Medicine, 2018.

[16] Chen Weijun. Study on the mechanism of COX-2 targeting microRNA-153 inhibiting proliferation and invasion of non-small cell lung cancer. Shandong University, 2017.

[17] Zhang Xiuqin. Study on the role and mechanism of B7-H4 in non-small cell lung cancer. Suzhou University, 2017.

[18] Jimei. The biological role and clinical significance of PD-L1 expression in non-small cell lung cancer. Suzhou University, 2016.

[19] Comparison and clinical significance of Feng Bei. P16 gene expression in non-small cell lung cancer. Yan'an University, 2015.

[20] Li Weimiao. The correlation between CREPT and expression of cell cycle D protein in non-small cell lung cancer and its clinical significance. Fourth Military Medical University, 2015.

[21] Punnoose EA, Atwal S, Liu W. Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib. Clin Cancer Res ,2012,18: 2391-2401.

[22] Harouaka R,Kang ZG,Zheng SY. Circulating tumor cells: Advances in isolation and analysis,and challenges for clinical applications. Pharmaco Ther, 2014, 141 (2): 209 - 221.

[23] Karhade M,Hall C,Mishra P. Circulating tumor cells in non-metastatic triple-negative breast cancer.Breast Cancer Res Treat, 2014,147(2):325 - 333.

[24] Macarthur KM, Kao GD, Chandrasekaran S. Detection of brain tumor cells in the peripheral blood by a telomerase promoterbased assay. Cancer Res. 2014,74:2152-2159.

[25] Ju M, Kao GD, Steinmetz D. Application of a telomerasebased circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study. Cancer Biol Ther, 2014,15:683-687.

[26] Hanssen, A., Wagner,J., Gorges, T. M. Characterization of different CTC subpopulations in non-small cell lung cancer. Scientific Reports, 2016,6(1).

[27] Gorges T M, Penkalla N, Schalk T. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clinical Cancer Research, 2016, 22(9): 2197-2206.